Clinic
Hennepin Healthcare System, INC
Hennepin Healthcare System, INC was paid $12.40M by Medicaid between Jan 2018 and Dec 2024, across 165 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoHENNEPIN HEALTHCARE SYSTEM, INC
MINNEAPOLIS, MN 55415
MINNEAPOLIS, MN 55415
33aNPI1710313895assigned 09/19/2013
33bProvider typeClinic/Center
28Total paid$12.40M
24GClaims356,897
24DCodes billed165
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Minnesota
Rank by total paid#5 of 250
Median peer was paid$274K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 78,283 | $528K | |
| 2019 | 66,246 | $1.81M | |
| 2020 | 44,969 | $1.29M | |
| 2021 | 65,376 | $2.24M | |
| 2022 | 38,760 | $2.24M | |
| 2023 | 34,462 | $2.31M | |
| 2024incomplete | 28,801 | $1.99M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 37,330 | 33,937 | $3.59M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 28,804 | 26,616 | $1.87M |
| J2357 | Injection, omalizumab, 5 mg | 6.7% | 809 | 476 | $826K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 5.4% | 14,919 | 14,506 | $664K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.8% | 3,061 | 2,838 | $470K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.8% | 24,476 | 23,484 | $350K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 2,804 | 2,764 | $263K |
| X5622 | 1.7% | 7,291 | 5,772 | $207K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.7% | 636 | 431 | $205K |
| 97810 | 1.6% | 4,613 | 2,666 | $199K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 2,296 | 2,286 | $198K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 3,005 | 2,906 | $189K |
153 more codes
| T1013 | Sign language or oral interpretive services, per 15 minutes | 1.5% | 12,043 | $188K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 2,186 | $188K |
| 95117 | 1.5% | 17,721 | $184K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 1,620 | $156K |
| 97811 | 1.2% | 4,566 | $151K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.2% | 7,988 | $146K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 4,459 | $140K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 807 | $134K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,185 | $119K |
| 36415 | Collection of venous blood by venipuncture | <1% | 34,241 | $114K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 5,573 | $98K |
| 92551 | <1% | 8,859 | $92K | |
| 96127 | <1% | 12,853 | $90K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,004 | $84K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,995 | $82K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,385 | $74K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 364 | $68K |
| 90686 | <1% | 12,768 | $68K | |
| 0002A | <1% | 1,365 | $60K | |
| 0001A | <1% | 1,569 | $59K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 615 | $57K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,498 | $55K |
| 91320 | <1% | 486 | $44K | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 2,064 | $39K |
| 99188 | <1% | 3,675 | $37K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,759 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,756 | $37K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 118 | $35K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,054 | $32K |
| 90480 | <1% | 860 | $32K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,145 | $31K |
| 90715 | <1% | 1,989 | $25K | |
| 90651 | <1% | 1,422 | $24K | |
| 85027 | <1% | 3,902 | $24K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 171 | $23K |
| 99173 | <1% | 8,790 | $21K | |
| 97162 | <1% | 239 | $20K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,651 | $19K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,218 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,526 | $17K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 270 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 994 | $16K |
| 98940 | <1% | 1,674 | $16K | |
| 0054A | <1% | 346 | $16K | |
| 99442 | <1% | 296 | $16K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 341 | $15K |
| 80061 | Lipid panel | <1% | 1,939 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,486 | $14K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 828 | $14K |
| 0124A | <1% | 397 | $14K | |
| 99443 | <1% | 173 | $14K | |
| 94375 | <1% | 258 | $13K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 120 | $13K |
| 0012A | <1% | 276 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,561 | $12K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 215 | $11K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 511 | $11K |
| 0011A | <1% | 231 | $11K | |
| 81025 | <1% | 1,362 | $10K | |
| 87430 | <1% | 967 | $9K | |
| 95012 | <1% | 309 | $8K | |
| 0004A | <1% | 236 | $8K | |
| 0072A | <1% | 168 | $8K | |
| 0071A | <1% | 167 | $7K | |
| 0064A | <1% | 174 | $7K | |
| 80076 | <1% | 1,360 | $6K | |
| 87210 | <1% | 1,451 | $6K | |
| 90473 | <1% | 471 | $6K | |
| 81003 | <1% | 2,589 | $5K | |
| 90677 | <1% | 112 | $5K | |
| 90656 | <1% | 687 | $5K | |
| 90670 | <1% | 1,810 | $5K | |
| 99385 | <1% | 79 | $5K | |
| 90662 | <1% | 153 | $5K | |
| 97813 | <1% | 53 | $4K | |
| 99384 | <1% | 25 | $4K | |
| 87081 | <1% | 960 | $4K | |
| 86803 | <1% | 316 | $3K | |
| 97814 | <1% | 53 | $3K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 460 | $3K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 37 | $3K |
| 97802 | <1% | 30 | $3K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 246 | $3K |
| 99441 | <1% | 99 | $3K | |
| 87088 | <1% | 318 | $3K | |
| 81001 | <1% | 1,067 | $3K | |
| 0052A | <1% | 52 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 29 | $3K |
| 85018 | <1% | 1,191 | $3K | |
| 0134A | <1% | 69 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $3K |
| 86592 | <1% | 957 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 67 | $2K |
| 87340 | <1% | 336 | $2K | |
| 99383 | <1% | 28 | $2K | |
| 90750 | <1% | 12 | $2K | |
| 83655 | <1% | 328 | $2K | |
| 0051A | <1% | 26 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 234 | $1K |
| G0008 | Administration of influenza virus vaccine | <1% | 236 | $1K |
| 90734 | <1% | 874 | $1K | |
| 87077 | <1% | 155 | $1K | |
| 90716 | <1% | 251 | $1K | |
| 94060 | <1% | 12 | $1K | |
| 99421 | <1% | 585 | $985.67 | |
| 86481 | <1% | 13 | $899.19 | |
| 99422 | <1% | 94 | $772.57 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 74 | $720.35 |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 12 | $715.50 |
| 86706 | <1% | 82 | $637.82 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 418 | $610.32 |
| 99607 | <1% | 17 | $602.70 | |
| 90474 | <1% | 195 | $567.92 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $547.41 |
| 97803 | <1% | 19 | $532.44 | |
| 82728 | <1% | 34 | $514.15 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 400 | $512.85 |
| 36416 | <1% | 155 | $457.56 | |
| 82043 | <1% | 60 | $280.36 | |
| 82570 | <1% | 87 | $264.46 | |
| 84466 | <1% | 17 | $245.63 | |
| 83540 | <1% | 30 | $221.48 | |
| 82947 | <1% | 64 | $207.60 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 37 | $194.44 |
| 86762 | <1% | 12 | $191.76 | |
| 86787 | <1% | 13 | $185.90 | |
| 82950 | <1% | 26 | $120.12 | |
| 82948 | <1% | 14 | $78.96 | |
| 82248 | <1% | 12 | $70.99 | |
| 90672 | <1% | 12 | $45.75 | |
| 83789 | <1% | 16 | $26.25 | |
| 83721 | <1% | 25 | $24.37 | |
| 84460 | <1% | 13 | $6.41 | |
| 84450 | <1% | 13 | $6.26 | |
| 90647 | <1% | 1,258 | $0.62 | |
| 90723 | <1% | 1,207 | $0.56 | |
| 90633 | <1% | 836 | $0.54 | |
| 90680 | <1% | 1,019 | $0.49 | |
| 90710 | <1% | 145 | $0.31 | |
| 90696 | <1% | 196 | $0.29 | |
| 90707 | <1% | 128 | $0.26 | |
| G2061 | Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes | 0% | 34 | $0.00 |
| 82607 | 0% | 12 | $0.00 | |
| 99072 | 0% | 2,780 | $0.00 | |
| 91300 | 0% | 343 | $0.00 | |
| 90681 | 0% | 12 | $0.00 | |
| 90700 | 0% | 79 | $0.00 | |
| 86480 | 0% | 12 | $0.00 | |
| 85610 | 0% | 21 | $0.00 | |
| 90685 | 0% | 106 | $0.00 | |
| 17110 | 0% | 40 | $0.00 | |
| H1000 | Prenatal care, at-risk assessment | 0% | 12 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, LISA (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Hennepin Healthcare System, INC | Minneapolis, MN | $708.86M |
| Hennepin Healthcare System, INC | Minneapolis, MN | $23.17M |
| Hennepin Healthcare System, INC | Minneapolis, MN | $638K |
| Hennepin Healthcare System INC | Minneapolis, MN | $294K |
| Beyond Wellness PLLC | Boise, ID | $234K |
| Hennepin Healthcare System INC | Minneapolis, MN | $20K |
| Hennepin Healthcare System, INC | Minneapolis, MN | $958.39 |
| Ets Consulting LLC | Mountlake Terrace, WA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.